EV Biologics (YECO) Stock Price, News & Analysis

Company Overview

EV Biologics, Inc., a biotechnology company, engages in the commercial development of extracellular vesicles (EVs) as biological modalities for diagnostics and therapeutics. It is involved in developing vaccines, therapeutics, and cures based on its proprietary multifunctional EV platform. The company also focuses on developing human mesenchymal and other stem cell, and cell-derived products to market in the cosmetic and biopharmaceutical spaces. The company was formerly known as Yulong Eco-Materials Limited and changed its name to EV Biologics, Inc. in August 2020. EV Biologics, Inc. was incorporated in 2011 and is headquartered in Cheyenne, Wyoming.

Key Stats

• Today's Range: $0.09 to $0.09
• 50-Day Range: $0.09 to $0.18
• 52-Week Range: $0.09 to $0.99
• Volume: N/A
• Average Volume: 5,023 shs
• Market Capitalization: $899,800.00
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

YECO Stock Analysis - Frequently Asked Questions

How have YECO shares performed this year?

EV Biologics' stock was trading at $0.0955 at the beginning of the year. Since then, YECO stock has decreased by 7.9% and is now trading at $0.0880.
View the best growth stocks for 2025 here.

How do I buy shares of EV Biologics?

Shares of YECO stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

What other stocks do shareholders of EV Biologics own?

Based on aggregate information from My MarketBeat watchlists, some other companies that EV Biologics investors own include Allena Pharmaceuticals (ALNA), American Electric Technologies (AETI), Ampliphi Biosciences (APHB), Pershing Gold (PGLC), Arbutus Biopharma (ABUS) and Aurora Cannabis (ACBFF).

Company Calendar

• Today: 2/23/2025
• Fiscal Year End: 6/30/2025

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Construction
• Industry: Concrete, gypsum, & plaster products
• Sub-Industry: Construction Materials
• Current Symbol: OTCMKTS:YECO
• CUSIP: N/A
• CIK: 1607741
• Web: www.evbiologics.com
• Phone: (518) 638-8192
• Fax: N/A
• Employees: 259
• Year Founded: N/A

Profitability

• EPS (Most Recent Fiscal Year): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: 10,225,000
• Free Float: 6,006,000
• Market Cap: $899,800.00
• Optionable: Not Optionable
• Beta: 0.06